Paige
Digital pathology AI applications for cancer pathology, including Paige Prostate.
Last updated: June 5, 2026
Back to directoryDigital pathology AI suite from Lunit for precision-oncology research, biomarker discovery, IHC analysis, and selected pathologist-assistive workflows.
Teams evaluating AI pathology analysis for oncology biomarker programs, immunotherapy research, trial enrichment, or governed pathology AI pilots with module-specific intended-use review.
Compare within workflow: Digital pathology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Lunit SCOPE as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Separate every SCOPE module, version, geography, study purpose, and intended use before deployment; research-use-only language on SCOPE IO, GP, uIHC, and IHC Suite pages should not be treated as diagnostic authorization. |
|---|---|
| Privacy | Review whole-slide image transfer, platform integrations, support access, annotations, study metadata, product-service data, de-identified data handling, retention, international transfers, and customer-contract privacy terms. |
| Evidence | Use Lunit's publication library, module-specific validation materials, and local pilot data to test scanner mix, tissue and stain quality, cancer subtype, biomarker endpoint, reproducibility, pathologist agreement, and trial-readout impact. |
| Workflow | Best governed as a module-specific digital pathology and biopharma analysis workflow with pathologist, translational science, clinical-trial, privacy, and regulatory review before outputs inform patient selection or reports. |
Lunit describes SCOPE as a precision-oncology digital pathology suite for H&E tumor microenvironment analysis, IHC biomarker strategy, genotype prediction, and PD-L1 quantification; its product pages label several SCOPE workflows as research use only and not for diagnostic procedures or decisions, while Lunit's publications and privacy materials provide evidence and data-handling context to verify before clinical or trial adoption.
Not for: Autonomous diagnosis, treatment selection, assuming all SCOPE modules are cleared for clinical use, or using research-use modules in diagnostic procedures or decisions.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.